Angela Crawley

Scientist, Chronic Disease Program · Ottawa Hospital Research Institute, Chronic Disease Program

Angela Crawley's lab studies the immunopathogenesis of HIV and hepatitis C (HCV) infection.

Biomedical Research Immunology Chronic Disease T-cell biology Hepatitis C Virus Infection (Hcv)

Haesuk Park

Associate Professor · University of Florida

Haesuk Park studies economic and health outcomes of medications and pharmaceutical care services and policy regarding pharmaceutical use.

Hepatitis C Claims Data Analysis Health Outcomes Pharmacoeconomics Policy Evaluations

Jason Rolls, M.D., FACS

Chief and Surgical Director of the Kidney Transplant Program · ChristianaCare

Dr. Rolls is Chief and Surgical Director of the Transplant Program. He provides care for those choosing kidney transplantation or donation.

Transplantation Immunosuppression Organ Donation General Surgery Abdominal Solid Organ Transplantation Dialysis Access Surgery

Guy El Helou

M.D./Clinical Assistant Professor · University of Florida

Dr. Guy El Helou is a clinical infectious disease physician with a special focus on infections in the transplant population.

Nontuberculous Mycobacteria Infections in Immunocompromised Patients Infectious Disease Infections in Transplant Recipients Cytomegalovirus infection

Lisa Holle, Pharm.D., BCOP, FHOPA

Associate Clinical Professor of Pharmacy Practice · University of Connecticut

Dr. Holle’s clinical research focuses on medical marijuana, oral cancer therapy management, and impact of clinical pharmacy services

MyDispense Medical Marijuana Pain Cancer Cancer Therapeutics

Imogen Coe

Dean, Faculty of Science · Ryerson University

Dr Imogen R. Coe is a scientist who is internationally recognized for her advocacy in promoting equity & diversity in science in Canada

Science Education Women in STEM Membrane Protein Cell Biology Membrane Protein Cell Biochemistry Clinical Research

Jose Vazquez, MD

Infectious Diseases · Augusta University

Dr. Jose Vazquez studies and treats infectious diseases, including COVID-19, antibiotic-resistant superbugs and fungal infections.

Coronavirus Translational Medicine in Infectious Diseases Drug-Resistant Infections (CREs, KPCs) Infectious Disease Clinical Trials Antimicrobials and Antifungals

Dr. Adey Nyamathi

Founding Dean and Distinguished Professor of Nursing · UC Irvine

Dr. Nyamathi conducts studies among vulnerable groups, including homeless, drug-addicted and incarcerated persons and gay/bisexual youth.

Vulnerable Populations Tuberculosis Role of Nursing Hiv/Aids Hepatitis

Felicia Wu

John A. Hannah Distinguished Professor · Michigan State University

Expert in food safety, social network analysis, global health, risk assessment, economic models, environmental health risks, public health

Social Network Models of Food Trade Immunotoxicology Social Network Modeling Public Health Environmental Health

Peter Gulick, DO FACP, FIDSA, FACOI

Professor of Medicine · Michigan State University

Take care of HIV/AIDS patients as well as Hepatitis C, B patients at 3 sites in Michigan

Hepatitis C Hiv/Aids Hepatitis B

B. Frank Gupton, Ph.D.

Floyd D. Gottwald, Jr. Chair in Pharmaceutical Engineering; Chair, Professor, Department of Chemical and Life Science Engineering · VCU College of Engineering

Professor Gupton's research is focused on the development of new technologies that will streamline organic synthesis

Cross-Coupling Catalysis Flow Chemistry / Continual Chemical Processing Organic Synthesis in Pharmaceutical Applications

Sandra Ka Hon Chu

Director of Research and Advocacy · Canadian HIV/AIDS Legal Network / Réseau juridique canadien VIH/sida

Human rights advocate for people living with, affected by and vulnerable to HIV.

Hiv / Aids Prison health Drug Policy Harm Reduction Sex Work and Prostitution Law

Thomas D. Roper, Ph.D.

Director, Pharmaceutical Engineering| Engineering Foundation Professor, Department of Chemical and Life Science Engineering · VCU College of Engineering

Dr. Roper specializes in efforts to bring engineering and science closer to patients who utilize medicines via novel technologies.

Metabolic Engineering and Biocatalysis 3D Printing of Dose Forms Long Acting Therapy Development Nanomaterials and Particle Sciences Continuous Chemical Reaction Engineering

Locke Bryan, PhD

Medical Hematologist-Oncologist · Georgia Cancer Center at Augusta University

A leading medical hematologist-oncologist who also specializes in Lymphomas Immunotherapy Novel Therapeutics.

Lymphomas Immunotherapy Novel Therapeutics

Lisa Yerian, MD

Medical Director, Continuous Improvement Director, Hepatobilliary Pathology; Assistant Professor of Pathology · Cleveland Clinic

An expert in continuous improvement in healthcare and continuous improvement tools including business intelligence dashboards

Leading Change and Organizational Culture Continuous Improvement in Healthcare Organizational Learning and Improvement Application in Continuous Improvement Principles

Asha Nayak-Kapoor, MD

Associate Professor of Medicine · Augusta University

Dr. Nayak's clinical and research interests are in GI Malignancies, and her specialties are Medical Hematology / Oncology Hematology.

Internal Medicine GI Malignancies Medical hematology/oncology

Dr. Ronald Blanton

Chair of Tropical Medicine, · Tulane University

Dr. Ronald Blanton is a physician-scientist who can speak about the global public health risks of COVID-19 and water-borne disease research.

COVID-19 Monitoring Task Force COVID-19 Community-based antimicrobial resistance Schistosomiasis Parasitic diseases